<SEC-DOCUMENT>0001104659-21-011508.txt : 20210203
<SEC-HEADER>0001104659-21-011508.hdr.sgml : 20210203
<ACCEPTANCE-DATETIME>20210203160225
ACCESSION NUMBER:		0001104659-21-011508
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210127
FILED AS OF DATE:		20210203
DATE AS OF CHANGE:		20210203

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lucsok Anna
		CENTRAL INDEX KEY:			0001843904

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38804
		FILM NUMBER:		21586167

	MAIL ADDRESS:	
		STREET 1:		9555 MAROON CIRCLE
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZYNEX INC
		CENTRAL INDEX KEY:			0000846475
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				870403828
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		9555 MAROON CIRCLE
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112
		BUSINESS PHONE:		(303) 867-3904

	MAIL ADDRESS:	
		STREET 1:		9555 MAROON CIRCLE
		CITY:			ENGLEWOOD
		STATE:			CO
		ZIP:			80112

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS INC
		DATE OF NAME CHANGE:	20050812

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZYNEX MEDICAL HOLDINGS   INC
		DATE OF NAME CHANGE:	20040120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOX RIVER HOLDINGS  INC
		DATE OF NAME CHANGE:	20031126
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tm215235d1_form3.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2021-01-27</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000846475</issuerCik>
        <issuerName>ZYNEX INC</issuerName>
        <issuerTradingSymbol>ZYXI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001843904</rptOwnerCik>
            <rptOwnerName>Lucsok Anna</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ZYNEX, INC.,</rptOwnerStreet1>
            <rptOwnerStreet2>9555 MAROON CIRCLE</rptOwnerStreet2>
            <rptOwnerCity>ENGLEWOOD</rptOwnerCity>
            <rptOwnerState>CO</rptOwnerState>
            <rptOwnerZipCode>80112</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>See Remarks</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Employee Stock Option (Right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>2.63</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2019-08-17</value>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2028-08-17</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee Stock Option (Right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.44</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2019-11-06</value>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2028-11-06</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee Stock Option (Right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>3.95</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2020-02-07</value>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2029-02-07</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Employee Stock Option (Right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>8.94</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2020-09-16</value>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <value>2029-09-16</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>5000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">On August 17, 2018, Zynex, Inc. (the &quot;Issuer&quot;) issued to Ms. Anna Lucsok (the &quot;Reporting Person&quot;) options to purchase 1,000 shares of the Company's common stock at an exercise price of $2.63 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on August 17, 2019.</footnote>
        <footnote id="F2">On November 6, 2018, the Issuer issued to the Reporting Person options to purchase 1,000 shares of the Company's common stock at an exercise price of $3.44 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on November 6, 2019.</footnote>
        <footnote id="F3">On February 7, 2019, the Issuer issued to the Reporting Person options to purchase 1,000 shares of the Company's common stock at an exercise price of $3.95 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on February 7, 2020.</footnote>
        <footnote id="F4">On September 16, 2019, the Issuer issued to the Reporting Person options to purchase 5,000 shares of the Company's common stock at an exercise price of $8.94 per share. The issuance was made pursuant to the Issuer's 2017 Stock Incentive Plan. The options vest in four equal annual installments commencing on September 16, 2020.</footnote>
    </footnotes>

    <remarks>Chief Operating Officer - Zynex Medical, Inc.</remarks>

    <ownerSignature>
        <signatureName>/s/ Anna Lucsok</signatureName>
        <signatureDate>2021-02-03</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
